Drug and Alcohol Dependence
Volume 65, Issue 3 , Pages 243-251 , 1 February 2002

Toluene inhalation produces regionally specific changes in extracellular dopamine

Received 20 March 2001 ,Revised 9 May 2001 ,Accepted 11 May 2001.

References 

  1. Ameno K, Kiriu T, Fuke C, Ameno S, Shinohara T, Ijiri I. Regional brain distribution of toluene in rats and in a human autopsy. Arch. Toxicol. 1992;66:153156
  2. Balster RL. Neural basis of inhalant abuse. Drug Alcohol Depend. 1998;51:207–214
  3. Balster RL, Schuster CR. Fixed interval schedule of cocaine reinforcement: effects of dose and infusion duration. J. Exp. Anal. Behav. 1973;20:119–129
  4. Beckstead MJ, Weiner JL, Eger EIN, Gong DH, Mihic SJ. Glycine and gamma-aminobutyric acid (A) receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 2000;57:1199–1205
  5. Bowen SE, Wiley JL, Balster RL. The effects of abused inhalants on mouse behavior in an elevated plus-maze. Eur. J. Pharmacol. 1996;312:131–136
  6. Bowen SE, Wiley JL, Jones HE, Balster RL. Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp. Clin. Psychopharmacol. 1999;7:28–37
  7. Carr DB, Sesack SR. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 2000;20:3864–3873
  8. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ. Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 1998;286:334–340
  9. Cruz, S.L., Balster, R.L., Woodward, J.J.1999. Neuronal bases of solvent abuse, Harris, L.S.,Problems of Drug Dependence NIDA Research Monograph 180. DHHS, NIH Pub No. 00-47372324, National Institute on Drug Abuse Bethesda MD, pp 23–24.
  10. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 1995;38:95–137 published erratum appears in Drug Alcohol Depend. 1995 Aug, 39(2): 155
  11. Evans EB, Balster RL. CNS depressant effects of volatile organic solvents. Neurosci. Biobehav. Rev. 1991;15:233–241
  12. Evans EB, Balster RL. Inhaled 1,1,1-trichloroethane-produced physical dependence in mice: effects of drugs and vapors on withdrawal. J. Pharmacol. Exp. Ther. 1993;264:726–733
  13. Flanagan RJ, Ives RJ. Volatile substance abuse. Bull. Narc. 1994;46:49–78
  14. Fuxe K, Andersson K, Nilsen OG, Toftgard R, Gustafsson J. Toluene and telencephalic dopamine: selective reduction of amine turnover in discrete DA nerve terminal systems of the anterior caudate nucleus by low concentrations of toluene. Toxicol. Lett. 1982;12:115–123
  15. Gardner EL. Brain reward mechanisms. In:  Lowinson J,  Ruiz P,  Millman RB,  Langrod J editor. Substance Abuse: A Comprehensive textbook. Baltimore: Wiliams and Wilkins; 1997;p. 51–85
  16. Garriott JC, Foerster E, Juarez L, de la Garza F, Mendiola I, Curoe J. Measurement of toluene in blood and breath in cases of solvent abuse. Clin. Toxicol. 1981;18:471–479
  17. Gerasimov MR, Dewey SL. Gamma-vinyl gamma-aminobutyric acid attenuates the synergistic elevations of nucleus accumbens dopamine produced by cocaine/heroin (speedball) challenge. Eur. J. Pharmacol. 1999;380:1–4
  18. Gerasimov MR, Franceschi M, Volkow N, Rice O, Schiffer WK, Dewey S. Synergistic interactions between nicotine and cocaine or methylphenidate depend on the dose of dopamine transporter inhibitor. Synapse. 2000;38:432–437
  19. Gerasimov, M.R., Ferrieri, R., Schiffer, W.K., Ashby, C., Garza, V., Shea, C., 2001. [11C] Toluene, a new radiotracer for imaging brain pharmacokinetics and biodistribution of a commonly abused solvent. Soc Nuc Med Abstr (In Press).
  20. Gospe SMJ, Calaban MJ. Central nervous system distribution of inhaled toluene. Fundam. Appl. Toxicol. 1988;11:540–545
  21. Hadfield MG, Nugent EA. Cocaine: comparative effect on dopamine uptake in extrapyramidal and limbic systems. Biochem. Pharmacol. 1983;32:744–746
  22. Hata N, Nishikawa T, Umino A, Takahashi K. Evidence for involvement of N-methyl-d-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex. Neurosci. Lett. 1990;120:101–104
  23. Hemby SE, Co C, Dworkin SI, Smith JE. Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (Speedball) in rats. J. Pharmacol. Exp. Ther. 1999;288:274–280
  24. Howard MO, Cottler LB, Compton WM, Ben-Abdallah A. Diagnostic concordance of DSM-III-R, DSM-IV, and ICD-10 inhalant use disorders. Drug Alcohol Depend. 2001;61:223–228
  25. King MD. Neurological sequelae of toluene abuse. Hum. Toxicol. 1982;1:281–287
  26. Kiriu T, Ameno K, Fuke C, Ameno S, Ijiri I. The distribution of toluene in the brain and its effects on the brain catecholamines in acute toluene poisoning. Nippon. Hoigaku. Zasshi. 1990;44:25–33
  27. Kishi R, Harabuchi I, Ikeda T, Yokota H, Miyake H. Neurobehavioural effects and pharmacokinetics of toluene in rats and their relevance to man. Br. J. Ind. Med. 1988;45:396–408
  28. Kondo H, Huang J, Ichihara G, Kamijima M, Saito I, Shibata E, et al. Toluene induces behavioral activation without affecting striated dopamine metabolism in the rat: behavioral and microdialysis studies. Pharmacol. Biochem. Behav. 1995;51:97–101
  29. Kozel, N. Epidemiology of inhalant abuse. An international perspective. (NIDA Res Monograph 148, NIH public #95-3831) 1995. Department of Health and Human Services, Rockville, MD, US.
  30. Lopez-Rubaclava C, Hen R, Cruz SL. Anxiolytic-like actions of toluene in the burying behavior and plus-maze test: differences in sensitivity between 5-HT1B knockout and wild-type mice. Behav. Brain. Res. 2000;115:85–94
  31. Moghaddam B, Bunney BS. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse. 1989;4:156–161
  32. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA. 1996;93:1325–1329
  33. Nishijima K, Kashiwa A, Nishikawa T. Preferential stimulation of extracellular release of dopamine in rat frontal cortex to striatum following competitive inhibition of the N-methyl-d-aspartate receptor. J. Neurochem. 1994;63:375–378
  34. Rees DC, Knisely JS, Breen TJ, Balster RL. Toluene, halothane, 1, 1, 1-trichloroethane and oxazepam produce ethanol-like discriminative stimulus effects in mice. J. Pharmacol. Exp. Ther. 1987;243:931–937
  35. Rees DC, Knisely JS, Jordan S, Balster RL. Discriminative stimulus properties of toluene in the mouse. Toxicol. Appl. Pharmacol. 1987;88:97–104
  36. Riegel AC, French ED. An electrophysiological analysis of rat ventral tegmental dopamine neuronal activity during acute toluene exposure. Pharmacol. Toxicol. 1999;85:37–43
  37. Riegel AC, French ED. The susceptibility of rat non-dopamine ventral segmental neurons to inhibition during toluene exposure. Pharmacol. Toxicol. 1999;85:44–46
  38. Schutz CG, Chilcoat HD, Anthony JC. The association between sniffing inhalants and injecting drugs. Compr. Psychiatry. 1994;35:99–105
  39. Sesack SR, Hawrylak V, Matus C, Guido MA, Levey AL. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci. 1998;18:2697–2708
  40. Stengard K, Hoglund G, Ungerstedt U. Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: a microdialysis study in awake, freely moving rats. Toxicol. Lett. 1994;71:245–255
  41. Tzschentke TM. The medial prefrontal cortex as a part of the brain reward system. Amino Acids. 2000;19:211–219
  42. von Euler G. Toluene and dopamenergic transmission. In:  Isaacson RL,  Jensen KF editor. The Vulnerable Brain and Environmental risks. 3:New York: Plenum Press; 1994;
  43. von Euler G, Fuxe K, Hansson T, Eneroth P, Agnati LF, Harfstrand A, et al. Effects of haloperidol treatment on regional catecholamine levels and utilization in rats exposed to toluene. Acta Physiol. Scand. 1988;132:199–208
  44. von Euler G, Ogren SO, Li XM, Fuxe K, Gustafsson JA. Persistent effects of subtonic toluene exposure on spatial learning and memory, dopamine-mediated locomotion activity and dopamine D2 agents binding in the rat. Toxicology. 1993;77:223–232
  45. von Euler M, Pham TM, Hillefors M, Bjelke B, Henriksson B, von Euler G. Inhalation of low concentrations of toluene induces persistent effects on a learning retention task, beam-walk performance, and cerebrocortical size in the rat. Exp. Neurol. 2000;163:1–8
  46. Wang T, French ED. NMDA, quaint, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum. Brain Res. Bull. 1995;36:39–43
  47. Weiss B, Wood RW, Macys DA. Behavioral toxicology of carbon disulfide and toluene. Environ. Health Perspect. 1979;30:39–45
  48. Westerink BH, Kwint HF, deVries JB. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral segmental area and nucleus accumbens of the rat brain. J. Neurosci. 1996;16:2605–2611
  49. Wood RW, Coleman JB, Schuler R, Cox C. Anticonvulsant and antipunishment effects of toluene. J. Pharmacol. Exp. Ther. 1984;230:407–412
  50. Yavich L, Patkina N, Zvartau E. Experimental estimation of addictive potential of a mixture of organic solvents. Eur. Neuropsychopharmacol. 1994;4:111–118

PII: S0376-8716(01)00166-1

doi: 10.1016/S0376-8716(01)00166-1

Drug and Alcohol Dependence
Volume 65, Issue 3 , Pages 243-251 , 1 February 2002

Article Tools

* Image Usage & Resolution